Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 90 days matching "awareness"

AdvocacyRSS3 days ago

Why Aren’t More Physicians Talking to Patients With AATD About Air Trapping?

A patient with AATD (alpha-1 antitrypsin deficiency) is raising awareness that doctors aren't talking enough with their patients about air trapping—a condition where air gets stuck in the lungs and doesn't come out properly. Air trapping is a common problem for people with AATD, but many patients don't understand what it is or how to manage it. Better patient education about this issue could help people with AATD breathe better and manage their condition more effectively.

WHY IT MATTERSPatients with AATD who understand air trapping can work with their doctors to use breathing techniques and medications that specifically target this problem, potentially improving their lung function and quality of life.
💬 Ask your doctorAlpha-1 Antitrypsin DeficiencyRead →
NewsRSS3 days ago

More Than a Heart Disease: Navigating the Stomach Issues of ATTR-CM

ATTR-CM is a rare heart disease caused by abnormal protein buildup, but many patients also experience serious stomach and digestive problems that doctors don't always talk about. These gastrointestinal issues—like difficulty swallowing, nausea, and poor nutrient absorption—can be just as challenging as the heart symptoms and significantly impact quality of life. The article highlights that patients need better awareness and support for managing these hidden digestive complications alongside their heart treatment.

WHY IT MATTERSATTR-CM patients often suffer from overlooked gastrointestinal complications that can worsen malnutrition and quality of life, yet these symptoms receive less medical attention than cardiac manifestations—understanding this connection helps patients advocate for comprehensive care.
💬 Ask your doctorATTR-CM (Transthyretin Amyloidosis with Cardiomyopathy)Read →
AdvocacyPUBMEDMar 26

"We are ambassadors, we are advocates": rare disease patient advocacy groups as knowledge brokers across health and social systems-a qualitative study from Poland.

This study looked at how patient groups led by people with rare diseases help fill gaps in education and awareness in Poland. Researchers interviewed 11 leaders of these patient groups to understand how they act as 'ambassadors' and 'advocates' to teach doctors, teachers, and the public about rare diseases. The findings show that patient advocacy groups play an important but often overlooked role in helping people understand and navigate rare diseases.

WHY IT MATTERSIf you have a rare disease, this research validates that patient-led advocacy groups are essential resources for getting accurate information and support when healthcare systems and professionals lack rare disease knowledge.
Good to knowRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases